08:00 , Mar 18, 2002 |  BioCentury  |  Finance

Ebb & Flow

The quiet shuttering of the doors at DoubleTwist serves as a reminder that even smart money can get cooked when chasing the latest trend. On the promise of the marriage between information technology and life...
08:00 , Mar 12, 2002 |  BC Extra  |  Company News

AHM buys PHA's APBiotech stake

Pharmacia (PHA) will sell to Amersham (AHM; LSE:AHM) its 45% holding in Amersham Biosciences (Little Chalfont, U.K.) for L704 million ($1 billion) in cash, giving AHM 100% ownership of the joint venture. PHA said the...
08:00 , Jan 28, 2002 |  BioCentury  |  Finance

NASDAQ IPO queue

NASDAQ IPO queue Company To be raised Shares Price range: Ribapharm $280.0M 20.0M $13-$15 APBiotech $254.8M 18.2M $15-$17 ZymoGenetics $170.0M 10.0M $16-18 Athena Diag $119.7M NA NA Aderis $100.0M NA NA CombiMatrix $100.0M NA NA...
07:00 , Jun 18, 2001 |  BC Week In Review  |  Company News

Gyros management update

Gyros AB , Uppsala, Sweden   Business: Microfluidics   Hired: Camilla Bondesson as VP of marketing, formerly marketing director of proteomics at APBiotech Inc.  ...
07:00 , Apr 16, 2001 |  BioCentury  |  Finance

Ebb & Flow

U.K. investors still are willing to dole out money only in dribs and drabs, as evidenced by the recent experiences of transgenics company PPL Therapeutics and cardiac device company Aortech . Thus for the foreseeable...
08:00 , Mar 26, 2001 |  BioCentury  |  Finance

Ebb & Flow

Thanks in part to a 3.6 percent gain on Friday, the BioCentury 100 closed the week down only 6 percent. The spate of bad news that poured out over the course of the week made...
08:00 , Mar 26, 2001 |  BioCentury  |  Finance

Ebb & Flow

Thanks in part to a 3.6 percent gain on Friday, the BioCentury 100 closed the week down only 6 percent. The spate of bad news that poured out over the course of the week made...
08:00 , Mar 5, 2001 |  BioCentury  |  Finance

Ebb & Flow

While hot life science technologies come and go, VCs are reminding themselves that patience, combined with fundamental investment strategies like targeting big markets, sound management and a solid business plan never go out of style....
07:00 , Oct 9, 2000 |  BioCentury  |  Finance

Beware the ides of October

The biotech industry last week joined its high tech compatriots with earnings warnings - some from companies, and some from sellside analysts - and the prophesies knocked $4.3 billion off the valuation of three companies...
07:00 , Oct 2, 2000 |  BC Extra  |  Financial News

APBiotech files for IPO

APBiotech (Piscataway, N.J.) filed to raise up to $100 million in an IPO that will be underwritten by Morgan Stanley Dean Witter; Goldman, Sachs; Chase H&Q; and Salomon Smith Barney. APBiotech ( Amersham Pharmacia Biotech)...